Literature DB >> 24450511

Oxidative stress in bisphosphonate-related osteonecrosis of the jaws.

Jose Bagan1, Guillermo T Sáez, M Carmen Tormos, Carmen Gavalda-Esteve, Leticia Bagan, Manuel Leopoldo-Rodado, Javier Calvo, Carlos Camps.   

Abstract

OBJECTIVES: To analyze whether oxidative stress (OS) changes are present in patients with bisphosphonate-related osteonecrosis of the jaw (BRONJ) versus controls.
MATERIALS AND METHODS: Oxidative stress was analyzed in serum and unstimulated saliva of three groups: Group 1 consisted of 24 patients who had been treated with intravenous bisphosphonates (ivBPs) and developed BRONJ, group 2 consisted of 20 patients who had received ivBPs and did not develop BRONJ, and group 3 comprised 17 control subjects. Reduced glutathione (GSH), malondialdehyde (MDA), oxidized glutathione (GSSG), and 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxo-dG) levels, as well as the GSSG/GSH ratio, were measured.
RESULTS: Mean serum and saliva levels of MDA, GSSG, and 8-oxo-dG and the GSSG/GSH ratio were significantly higher in patients with BRONJ than in controls. We found no significant difference in OS according to BRONJ stage, sex, or location in the jaws. Logistic regression analysis revealed that the GSSG/GSH ratio was a significant factor predicting the development of BRONJ (P = 0.01).
CONCLUSIONS: Oxidative stress was detected in patients with BRONJ, and the GSSG/GSH ratio was the most significant OS variable found; it was a significant factor predicting the development of BRONJ.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  8-oxo-dG; GSH; GSSG; MDA; bisphosphonate-related osteonecrosis; oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 24450511     DOI: 10.1111/jop.12151

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  12 in total

1.  Comments on "Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action".

Authors:  Maryam Khoubnasabjafari; Khalil Ansarin; Jalil Vaez-Gharamaleki; Abolghasem Jouyban
Journal:  Clin Oral Investig       Date:  2015-12-14       Impact factor: 3.573

2.  Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy.

Authors:  Valesca S Koth; Maria A Figueiredo; Fernanda G Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2017-02-17       Impact factor: 2.419

3.  Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ).

Authors:  Ioannis Gkouveris; Danny Hadaya; Akrivoula Soundia; Olga Bezouglaia; Yee Chau; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  Bone       Date:  2019-04-03       Impact factor: 4.398

Review 4.  Diabetes as a risk factor for medication-related osteonecrosis of the jaw.

Authors:  A Peer; M Khamaisi
Journal:  J Dent Res       Date:  2014-12-04       Impact factor: 6.116

5.  ANOM Approach for Statistical Evaluation of Some Antioxidant Enzyme Activities.

Authors:  Canan Demir; Sıddık Keskin; Fatih Şen
Journal:  Front Chem       Date:  2022-05-26       Impact factor: 5.545

Review 6.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09

7.  Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?

Authors:  L Bagan; Y Jiménez; M Leopoldo; A Rubert; J Bagan
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-09-01

Review 8.  Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches.

Authors:  Sung-Woon On; Seoung-Won Cho; Soo-Hwan Byun; Byoung-Eun Yang
Journal:  Antioxidants (Basel)       Date:  2021-04-27

9.  Salivary malondialdehyde as an oxidative stress biomarker in oral and systemic diseases.

Authors:  Maryam Khoubnasabjafari; Khalil Ansarin; Abolghasem Jouyban
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2016-06-15

Review 10.  Oxidative Stress Indexes for Diagnosis of Health or Disease in Humans.

Authors:  Martha A Sánchez-Rodríguez; Víctor Manuel Mendoza-Núñez
Journal:  Oxid Med Cell Longev       Date:  2019-11-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.